RANIBIZUMAB for Polypoidal choroidal vasculopathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 315 adverse event reports in the FDA FAERS database where RANIBIZUMAB was used for Polypoidal choroidal vasculopathy.
Most Reported Side Effects for RANIBIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,250 | 14.7% | 2,246 | 40 |
| Off label use | 1,467 | 9.6% | 100 | 96 |
| Visual acuity reduced | 1,342 | 8.8% | 28 | 158 |
| Visual impairment | 1,185 | 7.8% | 8 | 132 |
| No adverse event | 1,012 | 6.6% | 0 | 0 |
| Drug ineffective | 831 | 5.4% | 10 | 55 |
| Blindness | 760 | 5.0% | 9 | 80 |
| Vision blurred | 711 | 4.7% | 14 | 115 |
| Eye pain | 632 | 4.1% | 8 | 100 |
| Cerebrovascular accident | 543 | 3.6% | 60 | 258 |
| Endophthalmitis | 542 | 3.6% | 7 | 95 |
| Eye haemorrhage | 533 | 3.5% | 7 | 81 |
| Macular oedema | 471 | 3.1% | 3 | 31 |
| Vitreous floaters | 458 | 3.0% | 5 | 73 |
| Retinal haemorrhage | 437 | 2.9% | 9 | 63 |
Other Indications for RANIBIZUMAB
Neovascular age-related macular degeneration (3,867)
Product used for unknown indication (3,140)
Age-related macular degeneration (1,982)
Diabetic retinal oedema (1,872)
Choroidal neovascularisation (1,364)
Retinal vein occlusion (1,354)
Macular oedema (1,185)
Diabetic retinopathy (1,075)
Macular degeneration (637)
Type 2 diabetes mellitus (265)
Other Drugs Used for Polypoidal choroidal vasculopathy
VERTEPORFIN (210)
AFLIBERCEPT (193)
BROLUCIZUMAB (70)
BROLUCIZUMAB-DBLL (64)
BEVACIZUMAB (46)
FARICIMAB\FARICIMAB-SVOA (43)
FLUOROURACIL (17)
IRINOTECAN (17)
LEUCOVORIN (17)
LUCENTIS (7)